← FDA DRUG APPROVALS

FDA ANDA · ANDA206105

POLYETHYLENE GLYCOL 3350 NF

polyethylene glycol 3350

Sponsor: NUVO PHARMS INC

APPLICATION
ANDA206105
TYPE
ANDA
ORIGINAL APPROVAL
2016-10-28
LATEST ACTION
2023-02-09
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Over-the-counter

Products

POLYETHYLENE GLYCOL 3350Over-the-counter
POLYETHYLENE GLYCOL 3350 17GM/SCOOPFUL · FOR SOLUTION · ORAL

Approval history

2023-02-09Manufacturing (CMC) · Supplement 4 · unknownAP
2016-10-28UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →